Coty Under Investigation, Stock Plummets 15.56%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy COTY?
Source: Globenewswire
- Poor Financial Performance: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Withdrawal of Full-Year Guidance: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which could impact future market performance and investor expectations.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, affecting the company's reputation and shareholder interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.450
Low
2.50
Averages
4.30
High
10.00
Current: 2.450
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Merchandise Strategy Overhaul: Target plans to revamp its merchandise strategy over the next year, expecting net sales to rise about 2% compared to last year, addressing the challenge of four consecutive quarters of declining customer traffic.
- Fresh Food Expansion: The company will expand the square footage dedicated to fresh foods, planning to double the space in over half of its remodeled stores, aiming to attract more customers for one-stop shopping.
- Beauty Product Upgrade: Target will launch a 'Beauty Studio' in over 600 stores, replacing its partnership with Ulta Beauty, focusing on prestige beauty brands to attract younger consumers and boost sales.
- Home Goods Reconstruction: With home goods sales declining nearly 7% year-over-year, Target plans to rebuild the display area for these products over the next few years, expecting to redesign 75% of its home decor items to regain market competitiveness.
See More
- Poor Financial Performance: Coty reported non-GAAP earnings per share of $0.14 for Q2 FY2026, missing consensus estimates by $0.04, indicating a decline in profitability that may undermine investor confidence.
- Withdrawal of Full-Year Guidance: The company withdrew its full-year 2026 guidance and introduced a turnaround strategy focused on core brands, which could impact future market performance and investor expectations.
- Significant Stock Decline: Following the earnings report, Coty's stock price fell by $0.49, or 15.56%, closing at $2.66 per share on February 6, 2026, reflecting market concerns about the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Coty and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal risks and financial losses, affecting the company's reputation and shareholder interests.
See More
- Price Target Adjustment: Morgan Stanley lowered Coty Inc.'s price target from $4.25 to $3.50 while maintaining an Equal Weight rating, reflecting concerns over the company's Q2 performance, which was slightly below expectations, indicating market apprehension about future prospects.
- Poor Guidance: Coty Inc.'s Q3 EBITDA guidance fell significantly short of consensus estimates, with Morgan Stanley highlighting the withdrawal of fiscal 2026 guidance as a key negative factor, suggesting a lack of visibility that could undermine investor confidence moving forward.
- Leadership Transition Impact: Canaccord Genuity also reduced Coty's price target from $3.50 to $2.50, citing uncertainty surrounding the leadership transition and ongoing negative sales growth as critical reasons for the downgrade, which may diminish the company's competitive edge in the market.
- Investment Potential Analysis: While Coty is viewed as a potential investment, analysts suggest that certain AI stocks present greater upside potential and lower downside risk, indicating that investors should exercise caution in their selection process.
See More
- Earnings Miss: Coty reported a net loss of $126.9 million for Q2 2026, with non-GAAP EPS of $0.14, falling short of the $0.18 consensus estimate, leading to a 15% drop in after-hours trading and a 52-week low of $2.66, indicating severe underperformance relative to expectations.
- Industry Comparison: The loss is particularly notable against a backdrop of resilient demand in the global beauty and personal care sector, where peers like Estée Lauder and L'Oréal reported stable or improving margins, highlighting Coty's significant performance gap.
- Revenue Decline: Coty's like-for-like revenue fell approximately 3%, contrasting sharply with prior guidance of low-single-digit growth, suggesting a weakening competitive position that could impact future market share.
- Strategic Shift: The company withdrew its full-year FY 2026 guidance and introduced a new
See More
- Significant Financial Loss: Coty reported a net loss of $126.9 million for Q2 FY 2026, with non-GAAP EPS of $0.14, falling short of the $0.18 consensus estimate, leading to a 15% drop in after-hours trading and hitting a 52-week low.
- Industry Comparison Discrepancy: In a global beauty and personal care sector that has generally shown resilient demand, Coty's losses stand out, as peers like Estée Lauder and L'Oréal reported stable or improving margins in their latest quarters.
- Declining Revenue Trend: The company's like-for-like revenue declined approximately 3%, contrasting sharply with prior guidance of low-single-digit growth, indicating a significant gap between internal performance and public expectations, marking one of the widest earnings misses in the mid-cap consumer sector.
- Strategic Shift and Uncertain Outlook: Coty withdrew its full-year FY 2026 guidance and introduced a new
See More
- Brand Ambassador: Global superstar ROSALÍA has been appointed as the face of Calvin Klein's new fragrance line, euphoria elixirs, aiming to leverage her influence to attract younger consumers and enhance brand image.
- Product Launch: The euphoria elixirs collection features three distinct parfum intense creations, showcasing the brand's innovation in the fragrance market and expected to appeal to consumers seeking high-end scents.
- Market Strategy: By collaborating with a renowned artist, Calvin Klein aims to strengthen its position in the competitive fragrance market while expanding its reach through ROSALÍA's fan base.
- Brand Synergy: This partnership not only elevates Calvin Klein's brand visibility but may also drive sales growth for Coty Inc., further solidifying its market share in the fragrance industry.
See More






